Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Enterprise Value (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Enterprise Value data on record, last reported at -$665.0 million in Q3 2022.

  • For Q3 2022, Enterprise Value rose 20.8% year-over-year to -$665.0 million; the TTM value through Sep 2022 reached -$665.0 million, up 20.8%, while the annual FY2021 figure was -$764.4 million, 10.09% up from the prior year.
  • Enterprise Value reached -$665.0 million in Q3 2022 per AVIR's latest filing, up from -$684.5 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$17.1 million in Q1 2020 and bottomed at -$850.1 million in Q4 2020.
  • Average Enterprise Value over 3 years is -$581.6 million, with a median of -$705.5 million recorded in 2022.
  • Peak YoY movement for Enterprise Value: crashed 4762.37% in 2021, then increased 20.8% in 2022.
  • A 3-year view of Enterprise Value shows it stood at -$850.1 million in 2020, then rose by 10.09% to -$764.4 million in 2021, then increased by 13.0% to -$665.0 million in 2022.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$665.0 million in Q3 2022, -$684.5 million in Q2 2022, and -$705.5 million in Q1 2022.